ArticleACS medicinal chemistry lettersPublished
Discovery of 5‑Azaindole Inhibitors of O‑GlcNAcase for the Treatment of Alzheimer's Disease and Related Tauopathies
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- ACS medicinal chemistry letters
- Published
- Topic
- Disease research
- Subject terms
- Alzheimer’s disease; Tau Pathology; Structure-based Design; 5-Azaindole; O-glcnacase Inhibitors
- PubMed ID
- 42157845
- PubMed Central ID
- PMC13181490
- Open access
- Yes, free to read
- Added to directory
- Source checked